Insider · CIK 0001382218
Robert Canarick
Files at INBP (INTEGRATED BIOPHARMA INC). First filing -, latest -.
In brief
Robert Canarick files SEC Form 4 as director at INBP (INTEGRATED BIOPHARMA INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Canarick has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | INBP INTEGRATED BIOPHARMA INC | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 25, 2026 |
| Jun 18, 2025 | INBP INTEGRATED BIOPHARMA INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 20, 2025 |
| May 21, 2025 | INBP INTEGRATED BIOPHARMA INC | AGrant or award Common Stock | +175,000 | $0.09 | $16k | 234,233 | May 22, 2025 |
| May 21, 2025 | INBP INTEGRATED BIOPHARMA INC | DDisposition to issuer Stock Option (Right to Buy)derivative | -175,000 | $0.00 | $0 | 0 | May 22, 2025 |
Questions about Robert Canarick
Answered from the filings on this page, as of the latest one.
Is Robert Canarick buying or selling?
Robert Canarick has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Canarick's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Canarick has 0.
Where does Robert Canarick file Form 4?
Robert Canarick has filed Form 4 at INBP (INTEGRATED BIOPHARMA INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.